These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1317801)

  • 1. In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.
    Landínez R; Liñares J; Loza E; Martínez-Beltrán J; Martín R; Baquero F
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):265-7. PubMed ID: 1317801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
    Keşli R; Bilgin H; Yılmaz H
    Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
    Kilic S; Dizbay M; Cabadak H
    J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
    Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
    Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.
    Welsh L; Gaydos C; Quinn TC
    Antimicrob Agents Chemother; 1996 Jan; 40(1):212-4. PubMed ID: 8787907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
    Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
    Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
    Gutiérrez Altés A; Díez Enciso M; Peña García P; Campos Bueno A
    Antimicrob Agents Chemother; 1982 Mar; 21(3):501-3. PubMed ID: 6980624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
    Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
    Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Brucella spp to tetracycline and its analogues.
    Farrell ID; Hinchliffe PM; Robertson L
    J Clin Pathol; 1976 Dec; 29(12):1097-100. PubMed ID: 827554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
    Rennie KA; Prasad ES; Wenman WM
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
    Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
    J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of azithromycin against Brucella melitensis.
    Qadri SM; Halim MA; Ueno Y; Abumustafa FM; Postle AG
    Chemotherapy; 1995; 41(4):253-6. PubMed ID: 7555205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
    Halling SM; Jensen AE
    BMC Microbiol; 2006 Oct; 6():84. PubMed ID: 17014718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Brucella melitensis to fluoroquinolones.
    Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
    Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of clinical isolates of Brucella.
    Mortensen JE; Moore DG; Clarridge JE; Young EJ
    Diagn Microbiol Infect Dis; 1986 Jul; 5(2):163-9. PubMed ID: 3720265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
    Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
    J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
    Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
    Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.